Lack of Risk of Adverse Birth Outcomes After Deworming in Pregnant Women

  title={Lack of Risk of Adverse Birth Outcomes After Deworming in Pregnant Women},
  author={Theresa W Gyorkos and Ren{\'e}e Larocque and Martin Casapia and Eduardo Gotuzzo},
  journal={The Pediatric Infectious Disease Journal},
Background: Pregnant women who live in hookworm-endemic areas may benefit from deworming during their pregnancy. The benefit derives from reducing anemia, primarily iron-deficiency anemia caused by hookworm infection-attributable blood loss. Where the prevalence of hookworm is more than 20% to 30%, the World Health Organization recommends that pregnant women receive anthelminthic treatment (mebendazole, albendazole, levamisole or pyrantel) after their first trimester. The objective of this… 

Antenatal Deworming and Materno-Perinatal Outcomes in Calabar, Nigeria

Presumptive deworming during the antenatal period can significantly reduce the incidence of peripartum anaemia, however, more studies may be needed to prove any positive perinatal outcome.

Hookworm-Related Anaemia among Pregnant Women: A Systematic Review

Evidence indicates that increasing hookworm infection intensity is associated with lower haemoglobin levels in pregnant women in poor countries and efforts should be made to increase the coverage of anthelmintic treatment among pregnant women.

Antihelminthics in pregnancy and maternal, newborn and child health.

Results from observational studies suggest a potential benefit on maternal anaemia, birthweight and infant mortality, and further trials examining the effect of antihelminthics starting in the second trimester of pregnancy in poor, STH-endemic regions with high rates of anaemia are needed.

Malaria, Intestinal Helminths and Other Risk Factors for Stillbirth in Ghana

The fact that most of the stillbirths were fresh suggests that higher quality intrapartum care could reduce stillbirth rates.

Complex Interactions between Soil-Transmitted Helminths and Malaria in Pregnant Women on the Thai-Burmese Border

A. lumbricoides and hookworm appear to have contrary associations with malaria in pregnancy on the Thai-Burmese border, and the relationship between geohelminth infection and the progress and outcome of pregnancy was assessed.

Effect of administration of antihelminthics for soil-transmitted helminths during pregnancy.

Analysis showed that administration of a single dose of antihelminthic in the second trimester of pregnancy is not associated with any impact on maternal anaemia in the third trimester, and more well-designed, large scale randomised controlled trials are needed to establish the benefit of anti Helminthics treatment during pregnancy.

Toward Comprehensive Interventions to Improve the Health of Women of Reproductive Age

Given the established relationship between hookworm and iron deficiency, hookworm treatment is likely to positively affect maternal and infant health, though the timing of treatment as well as provision of micro-nutrient supplementation are key factors discussed further below.

Prevalence of intestinal helminth infections among pregnant women attending antenatal clinics at the Kitale District Hospital, Kenya

It was concluded that intestinal helminth infections were prevalent among pregnant women and it was recommended that all expectant women visiting antenatal clinics be screened for intestinal helmineth infections and positive cases be advised to seek treatment.

Effect of Malaria and Geohelminth Infection on Birth Outcomes in Kumasi, Ghana

The prevalence of malaria, helminths and adverse birth outcomes was lower than previously reported and helminth but not malaria infection was found to be significantly associated with adverseBirth outcomes.

Prevalence and risk factors for intestinal parasitic infections in pregnant women residing in three districts of Bogotá, Colombia

Higher but not statistically significant associations were found between any parasite and women living with a partner, and intestinal polyparasitism and being from a minority group and not having a water sink, and the need for educational interventions to disrupt transmission routes for prevalent parasites.



Pregnancy outcome after gestational exposure to mebendazole: a prospective controlled cohort study.

This study suggests that mebendazole does not represent a major teratogenic risk in humans when it is used in the doses that are used commonly for pinworm (Enterobius vermicularis) infestation.

Albendazole therapy and reduced decline in haemoglobin concentration during pregnancy (Sierra Leone).

  • H. TorlesseM. Hodges
  • Medicine
    Transactions of the Royal Society of Tropical Medicine and Hygiene
  • 2001

Hookworm infection in pregnancy.

Relationship between intensity of soil-transmitted helminth infections and anemia during pregnancy.

The results support routine anthelminthic treatment within prenatal care programs in highly endemic areas of Peru and suggest a direct relationship exists between the intensity of hookworm infection and blood loss.

Population‐based case–control study of mebendazole in pregnant women for birth outcomes

The objective of the study was to check the embryotoxic‐teratogenic and fetotoxic effect of mebendazole treatment during pregnancy and in matched control mothers of babies born without congenital abnormalities in the population‐based data set of the Hungarian Case–Control Surveillance of Congenital Abnormalities between 1980 and 1996.

The public health importance of hookworm disease

The latest evidence confirms that blood loss caused by the worms' feeding activity in the gut is a contributing factor in the development of poor iron status leading to iron-deficiency anaemia.

Tropical obstetrics and gynaecology. 1. Anaemia in pregnancy in tropical Africa.

  • A. Fleming
  • Medicine
    Transactions of the Royal Society of Tropical Medicine and Hygiene
  • 1989

Prevention and control of schistosomiasis and soil-transmitted helminthiasis.

  • Medicine
    World Health Organization technical report series
  • 2002
The report stresses that the cost of recommended anthelminthic drugs has now fallen to a level at which it should no longer deter Member States from making treatment widely available in endemic areas and provides clear and strategic guidance on the implementation of control measures and on ensuring their sustainability.